With this Funding, We’re Taking a Major Step Towards the Clinical Validation of our Technology in Glaucoma and then in Macular Edema: Jean Garrec of BIOPHTA
“Our ambition does not stop here, and we remain fully dedicated to bringing sight-saving therapies to all patients in need of simple and efficient treatments,” said Jean Garrec, founder and CEO of BIOPHTA.”